Generics US generic drugmaker Mylan (Nasdaq: MYL) has confirmed that it has been sued by Takeda Pharmaceutical (TYO: 4502), Watson Pharmaceuticals (NYSE: WPI) and privately-held Andrx Labs in connection with the filing of an Abbreviated New Drug Application with the US Food and Drug Administration for pioglitazone hydrochloride and extended-release metformin HCL tablets, 15mg/1,000mg and 30mg/1,000 mg. This product is the generic version of Takeda's Actoplus Met XR, which is indicated to improve glycemic control in adults with type 2 diabetes mellitus. 9 January 2012